EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseUmbrella ReviewOpen Access · CC BY 4.0

Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses

Qitong Jiang, Tian Li, Lei Zhao, Yue Sun, Zhen Mao, Yujie Xing, Chuanyue Wang, Qijing Bo

Frontiers in Psychiatry · 05.03.2024 · 15

DOI: 10.3389/fpsyt.2024.1337274 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 05.03.2024. Verfasst von Qitong Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institute for Brain Disorders Cente…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperprolactinemia is a common antipsychotic-induced adverse event in psychiatric patients, and the quality of clinical studies investigating the best treatments has varied. Thus, to better summarize the clinical evidence, we performed an umbrella review of overlapping systematic reviews and meta-analyses for the treatment of antipsychotic-induced hyperprolactinemia.

Methods

The PubMed, Cochrane Library, PsycINFO, Scopus and EMBASE were searched, and reviews and meta-analyses meeting our inclusion criteria were selected. Relevant data were extracted, and an umbrella review was conducted of all included meta-analyses. The quality of included meta-analyses was assessed by using PRISMA scores and AMSTAR 2 quality evaluation. Finally, the clinical evidence for appropriate treatments was summarized and discussed.

Results

Five meta-analyses published between 2013 and 2020 met the requirements for inclusion in this umbrella review. The PRISMA scores of the included meta-analyses ranged from 19.5–26. AMSTAR 2 quality evaluation showed that 2 of the 5 included meta-analyses were of low quality and 3 were of very low quality. The included meta-analyses provide clinical evidence that adding aripiprazole or a dopamine agonist can effectively and safely improve antipsychotic-induced hyperprolactinemia. Two meta-analyses also showed that adjunctive metformin can reduce serum prolactin level, but more clinical trials are needed to confirm this finding.

Conclusion

Adjunctive dopamine agonists have been proven to be effective and safe for the treatment of antipsychotic-induced hyperprolactinemia. Among the researched treatments, adding aripiprazole may be the most appropriate.

Schlagwörter

Stichwörter der Autor:innen

adverse effectsantipsychoticaripiprazoledopamine agonistshyperprolactinemiametforminumbrella review

Autor:innen und Institutionen

  • The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical Universit…
  • Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.

Zitieren

APA

Jiang, Q., Li, T., Zhao, L., Sun, Y., Mao, Z., Xing, Y., Wang, C., & Bo, Q. (2024). Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1337274

Vancouver

Jiang Q, Li T, Zhao L, Sun Y, Mao Z, Xing Y, et al. Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses. Frontiers in Psychiatry. 2024;15. doi:10.3389/fpsyt.2024.1337274

BibTeX
@article{Jiang2024,
  author = {Jiang, Qitong and Li, Tian and Zhao, Lei and Sun, Yue and Mao, Zhen and Xing, Yujie and Wang, Chuanyue and Bo, Qijing},
  title = {Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses},
  journal = {Frontiers in Psychiatry},
  year = {2024},
  volume = {15},
  doi = {10.3389/fpsyt.2024.1337274}
}
Kostenlos starten →